Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, February 01, 2015
 
Register | Sign in
Home Page>Products
  Product News
SP Acquires Stability Environments
Friday, January 23, 2015
A global provider of walk-in environmental rooms, glassware dryers, chambers and accessory products.

Analytik Jena Launches CE IvD Kits for Dementia Diagnostics
Friday, January 23, 2015
Kits are easy and quick to use, and are well suited to automation on the relevant platforms in routine diagnostics.

Automated Catalyst Characterization
Friday, January 23, 2015
Catlab PCS combined microreactor and mass spectrometer system from Hiden.

Oxford Instruments Asylum Research Releases New Application Note
Thursday, January 22, 2015
“AFM Applications in Polymer Science and Engineering,” written by Dr. Donna Hurley.

Illumina Announces First Targeted NGS Solution for Forensic Genomics
Thursday, January 22, 2015
MiSeq FGx™ forensic genomics system brings sample-to-answer sequencing to forensic laboratories.

4.0 Release of Partek Flow Data Analysis Software
Thursday, January 22, 2015
Align, analyze, and visualize next generation sequencing data in users browser.

Higher Resolution and Greater Sample Capacity
Thursday, January 22, 2015
New Clarit-E® choice stretch horizontal electrophoresis tank.

Irvine Scientific Introduces PRIME-XV® T Cell Culture Medium
Wednesday, January 21, 2015
A xeno-free and serum-free medium for immunotherapy applications.

SYGNIS Announces the Global Launch of TruePrime™ Single Cell WGA Kit
Wednesday, January 21, 2015
First product launched for single cell DNA amplification.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 10846
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn